Addiction traps individuals, disrupts families, and affects entire communities. SRI addiction research investigates the causes of addiction, preventive measures, and treatments to stop the downward spiral of addiction.
Drug Abuse Research
For clients such as the National Institutes of Health (NIH), SRI researchers conduct neuropharmacology studies to discover nonaddictive analgesics. They also perform substance abuse research to investigate the relationship between analgesia and addiction, focusing on opiate receptors and the recently discovered opiate-like receptor ORL1.
To understand the molecular basis of addiction, SRI conducts drug addiction research to study the receptor pharmacology of addictive compounds, including opiates and cocaine analogs. They also conduct drug abuse research for the National Institute on Drug Abuse to generate receptor binding data for the research community at large.
Nicotine Addiction Research
SRI's Center for Health Sciences has long been recognized for its leading nicotine addiction research. For NIH and other clients, SRI examines the predictors of relapse to nicotine addiction and the influence of genetics on smoking. Nicotine research aims to identify subpopulations at high risk for relapse after nicotine replacement therapy and genetic mutations that may be common among users of alcohol, coffee, and nicotine.
Additional sponsors include the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, and the University of California Tobacco-Related Disease Research Fund.